186593-42-0

Basic information

• Product Name: 3-BROMO-2-METHYL-5-NITROPYRIDINE
• Synonyms: 3-BROMO-2-METHYL-5-NITROPYRIDINE;3-Bromo-5-Nitro-2-Picoline;3-Bromo-2-methyl-5-nitrop...;2-Methyl-3-broMo-5-nitropyridine
• CAS NO: 186593-42-0
• Molecular Formula: C₆H₅BrN₂O₂
• Molecular Weight: 217.0201
• Product Categories: Heterocycle-Pyridine series
• Mol File: 186593-42-0.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 270.586 °C at 760 mmHg
• Flash Point: 117.447 °C
• Appearance: /
• Density: 1.709 g/cm³
• Vapor Pressure: 0.0113mmHg at 25°C
• Refractive Index: 1.599
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: -0.44±0.20(Predicted)
• CAS DataBase Reference: 3-BROMO-2-METHYL-5-NITROPYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-2-METHYL-5-NITROPYRIDINE(186593-42-0)
• EPA Substance Registry System: 3-BROMO-2-METHYL-5-NITROPYRIDINE(186593-42-0)

Safety Data

• Hazardous Substances Data: 186593-42-0(Hazardous Substances Data)

Usage

General Description

3-Bromo-2-methyl-5-nitropyridine is a chemical compound with the molecular formula C6H5BrN2O2. It is a nitropyridine derivative that is commonly used as a building block in the synthesis of various pharmaceuticals and agrochemicals. This chemical is a yellow solid with a melting point of 48-50°C and a boiling point of 119-121°C. It is primarily used as an intermediate in the production of active pharmaceutical ingredients and other organic compounds. 3-Bromo-2-methyl-5-nitropyridine is also used as a reagent in organic synthesis and can be found in research laboratories and industrial settings where it is utilized for a variety of applications.

InChI:InChI=1/C6H5BrN2O2/c1-4-6(7)2-5(3-8-4)9(10)11/h2-3H,1H3

Upstream product

• 5470-17-7 3-bromo-2-chloro-5-nitropyridine 
• 105-53-3 diethyl malonate 
• 28290-06-4 disodium 2,2-diethylamalonate 
• 15862-33-6 3-bromo-2-hydroxy-5-nitropyridine 
• 5418-51-9 5-nitro-2-hydroxypyridine 
• 15862-36-9 2,3-dibromo-5-nitropyridine 

Downstream Products

• 1621225-24-8 5-chloro-2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine 
• 131036-39-0 3-bromo-5-chloro-2-methylpyridine 
• 1008138-66-6 2-methyl-5-nitro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine 
• 186593-43-1 5-amino-3-bromo-2-methylpyridine 
• 895519-84-3 4-((4-ethylpiperazin-1-yl)methyl)-N-(6-methyl-5-(4-(pyridin-3-yl)pyrimidin-2-ylamino)pyridin-3-yl)benzamide 
• 1008138-81-5 methyl 4-(2-methyl-5-nitropyridin-3-yl)benzoate 

Relevant articles and documents

BORON-CONTAINING SMALL MOLECULES

Compounds, pharmaceutical formulations, and methods of treating bacterial infections are disclosed.

A 2-amino-thiazole compounds (by machine translation)

The present invention relates to the technical field of pharmaceutical chemistry, particularly relates to a 2-amino thiazole compound or its pharmaceutically acceptable salts, its preparation method, and pharmaceutical compositions containing such compounds and its application in the preparation of antineoplastic. (by machine translation)

Arylthiobenzylpiperidine derivatives

This invention is directed to Arylthiobenzylpiperidine derivatives which are ligands at the MCH1 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from obesity which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention.